bumetanide has been researched along with Allergic Encephalomyelitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bumetanide, an NKCC inhibitor, had no effect on mechanical hypersensitivity seen in mice with EAE even though it reversed the changes in the levels of NKCC1 and KCC2." | 1.46 | The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE). ( Kerr, B; Tenorio, G; Yousuf, MS; Zubkow, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yousuf, MS | 1 |
| Zubkow, K | 1 |
| Tenorio, G | 1 |
| Kerr, B | 1 |
1 other study available for bumetanide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
Topics: Animals; Bumetanide; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Gangl | 2017 |